| Recruiting | Virtual Reality (VR) Self-Hypnosis Software NCT06398847 | Icahn School of Medicine at Mount Sinai | N/A |
| Recruiting | Perioperative Medical Program to Optimize Nerve Regeneration After Robot-assisted Laparoscopic Neurolyses of P NCT06796595 | UBOSGA | — |
| Recruiting | Treatment of Upper Limb Chronic Neuropathic Pain by Electrical Stimulation of the Brachial Plexus Nerve Roots NCT05817786 | Centre Hospitalier Universitaire de Nice | N/A |
| Suspended | The Use of Exosomes In Craniofacial Neuralgia NCT04202783 | Neurological Associates of West Los Angeles | N/A |
| Withdrawn | Long-term Effects of Repetitive TMS in Chronic Neuropathic Pain in People With SCI NCT05226676 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Botulinum Toxin for Chronic Neuropathic Pain NCT06036043 | Region Zealand | — |
| Completed | Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Ne NCT05935956 | NeuraLace Medical, Inc. | — |
| Completed | PK of Lidocaine/Tetracaine and PD Derived From a New Topical Formulation for Treatment of Neuropathic Pain. NCT06171243 | Pontificia Universidad Catolica de Chile | — |
| Completed | Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventi NCT05620225 | NeuraLace Medical, Inc. | N/A |
| Completed | High Voltage VS Standard Voltage Radiofrequency in a Patient With Failed Back Surgery Syndrome NCT05563636 | Assiut University | N/A |
| Completed | Home-based EEG Neurofeedback for Chronic Neuropathic Pain NCT05464199 | East Kent Hospitals University NHS Foundation Trust | Phase 1 |
| Enrolling By Invitation | Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery NCT05315596 | Jena University Hospital | — |
| Completed | Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial NCT04700033 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M NCT04066933 | Neurological Associates of West Los Angeles | — |
| Unknown | Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin Pathway NCT03513822 | Redar | Phase 3 |
| Completed | Examining Carryover Effect in Patients Treated witH Spinal cOrd Stimulation (ECHO) NCT03386058 | University of Aarhus | N/A |
| Completed | Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropath NCT03315598 | Seoul National University | N/A |
| Terminated | Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life NCT03296111 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Unknown | Intra-operative Lidocaine Infusion in Preventing CPSP Post VATs NCT02862769 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 4 |
| Completed | Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Po NCT03009500 | University Health Network, Toronto | Phase 3 |
| Completed | EMONO for the Treatment of Peripheral Neuropathic Pain NCT02957851 | Air Liquide Santé International | Phase 2 |
| Completed | Comparison of Ultrasound-guided Transgluteal and Finger-guided Transvaginal Pudendal Nerve Block Techniques NCT03973983 | Derince Training and Research Hospital | N/A |
| Terminated | Transcranial Direct Current Stimulation (tDCS) in Chronic Neuropathy NCT02747758 | Charite University, Berlin, Germany | N/A |
| Unknown | Peripheral Physiological Measures as Determinants of Pain Risk NCT02985294 | Neuroscience Technologies SLP, Barcelona | — |
| Completed | Novel Treatment Option for Neuropathic Pain NCT02490436 | Sorlandet Hospital HF | Phase 2 |
| Completed | Evaluation of Spinal Cord Stimulation Pulse Rate On Clinical Outcomes NCT02549183 | Mid and South Essex NHS Foundation Trust | N/A |
| Terminated | Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy NCT02460107 | Catholic University of Korea Saint Paul's Hospital | EARLY_Phase 1 |
| Completed | Ketamine and fMRI for Neuropathic Pain NCT02373449 | University Health Network, Toronto | N/A |
| Completed | Influence of Dexmedetomidine and Lidocaine on Opioid Consumption in Laparoscopic Intestine Resection NCT02616523 | University Medical Centre Ljubljana | Phase 4 |
| Completed | Examination of the Pathophysiologic Mechanisms of CRPS by Using QST, CPM, RIC, and Heart Rate Variability QST NCT02261012 | Ruhr University of Bochum | — |
| Terminated | Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain NCT01899170 | University of Aarhus | Phase 2 |
| Completed | Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain NCT04737278 | Mitosynergy LLC | Phase 1 / Phase 2 |
| Completed | GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain NCT01974791 | Boston Children's Hospital | N/A |
| Terminated | Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty NCT02885467 | Medstar Health Research Institute | N/A |
| Recruiting | MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine NCT01788410 | Brigham and Women's Hospital | — |
| Completed | Study to Evaluate the Efficacy of Lithium Carbonate in Spinal Cord Injury Patients With Neuropathic Pain NCT01855594 | China Spinal Cord Injury Network | Phase 2 |
| Completed | 3D Augmented Reality Mirror Visual Feedback Applied to the Treatment of Unilateral Upper Extremity Neuropathic NCT02582216 | Erasme University Hospital | Phase 1 / Phase 2 |
| Completed | Symptom Based Treatment of Neuropathic Pain NCT02180880 | Ju Seok Ryu | Phase 4 |
| Terminated | A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripher NCT01485094 | Grünenthal GmbH | Phase 2 |
| Withdrawn | Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study NCT01298466 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 |
| Completed | Effects of Pennsaid on Clinical Neuropathic Pain NCT01508676 | Massachusetts General Hospital | N/A |
| Unknown | Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain NCT01264237 | Analgesic Solutions | Phase 4 |
| Completed | Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan) NCT01256593 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | — |
| Terminated | The Effect of Soy Protein on Neuropathic Pain NCT01050244 | Dr. Yoram Shir | Phase 2 |
| Completed | Somatosensory Investigation of Orofacial Pain Patients NCT02910336 | University of Sao Paulo | — |
| Completed | Persistent Pain After Breast Cancer Treatment With Docetaxel NCT01279018 | Rigshospitalet, Denmark | — |
| Completed | An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain NCT01202227 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 |
| Unknown | Development of a Bedside Pain Assessment Kit for Postherpetic Neuralgia NCT01166295 | Analgesic Solutions | — |
| Completed | A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to NCT01124617 | Janssen Pharmaceutical K.K. | Phase 2 |
| Unknown | To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients W NCT00944502 | Bunker Industria Farmaceutica Ltda. | Phase 3 |
| Terminated | A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain ( NCT00964990 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Completed | Clinical Study With Lyrica In Patients Suffering From Epilepsy NCT00922987 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | — |
| Unknown | Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer NCT00740571 | Radboud University Medical Center | Phase 3 |
| Completed | Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire. NCT00599768 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | — |
| Terminated | Safety and Efficacy of AGN201781 in Neuropathic Pain NCT00533351 | Allergan | Phase 2 |
| Completed | Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With P NCT00592774 | Eisai Inc. | Phase 2 |
| Completed | Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (P NCT00592904 | Eisai Inc. | Phase 2 / Phase 3 |
| Completed | A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Periphera NCT00476151 | EpiCept Corporation | Phase 2 |
| Completed | Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica NCT00541476 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | — |
| Completed | An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN). NCT00492323 | SK Life Science, Inc. | Phase 2 |
| Completed | A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury NCT00407745 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 |
| Completed | Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NCT00300222 | NeurogesX | Phase 3 |
| Completed | P4 (Pregabalin for Peripheral Posttraumatic Pain) NCT00292188 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 |
| Completed | Pregabalin Peripheral Neuropathic Pain Study NCT00141219 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 |
| Completed | Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (P NCT00233155 | NeurogesX | Phase 2 |
| Unknown | The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy NCT00134524 | Advanced Magnetic Research Institute International | Phase 3 |
| Completed | Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NCT00115310 | NeurogesX | Phase 3 |
| Completed | A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain NCT00631943 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 |
| Completed | A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing NCT00674687 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | N/A |
| Unknown | Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia NCT00099528 | Renovis | Phase 2 |
| Completed | KETOR: Effects of Peri Operative Administration of Ketamine on Long Term Post Thoracotomy Pain NCT00224588 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Terminated | Efficacy of Valproate in Peripheral Neuropathic Pain NCT00221637 | University Hospital, Bordeaux | Phase 2 / Phase 3 |
| Completed | Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain NCT00034710 | NeurogesX | Phase 2 |
| Completed | To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia. NCT00150436 | Pfizer | Phase 3 |
| Completed | Dextromethorphan Versus Placebo for Neuropathic Pain NCT00001344 | National Institute of Dental and Craniofacial Research (NIDCR) | Phase 2 |
| Completed | Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropat NCT00082316 | NeurogesX | Phase 2 |
| Completed | Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia NCT00068081 | NeurogesX | Phase 3 |
| Terminated | An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain NCT00089557 | NeurogesX | Phase 2 |
| Completed | NGX-4010 for the Treatment of Postherpetic Neuralgia NCT00061776 | NeurogesX | Phase 2 / Phase 3 |